Navigation Links
Healionics Awarded $900k Grant from NIH
Date:9/20/2012

SEATTLE, Sept. 20, 2012 /PRNewswire/ -- Healionics Corporation received a $909,165 Phase II Small Business Innovation Research (SBIR) grant award from the National Institute of General Medical Sciences division of the National Institutes of Health (NIH) for preclinical studies to advance STARcuffTM, a STAR® Biomaterial-based anti-infective exit site sleeve for hemodialysis catheters. Andrew Marshall, Healionics' Chief Technology Officer, is the Principal Investigator for this research project.

(Logo: http://photos.prnewswire.com/prnh/20120920/SF77922LOGO)

Titled, "Anti-Infective Dermal Integration Sleeves for Needle-Free Dialysis Access Devices," the award provides funding to refine the STARcuff anti-infection technology and broaden its range of device applicability.

Hemodialysis patients are at high risk for life-threatening bloodstream infections. Treatment of catheter-associated infections at $35,000 to $60,000 per episode exceeds the yearly cost of routine dialysis sessions. Nearly half of these infections proceed extraluminally via the exit site.

"Catheters loaded with active antimicrobial agents or antiseptics are a controversial option for chronic dialysis patients due to the serious threat of microbial resistance," says Marshall. "STARcuff is an attractive approach because it can potentially provide long-term protection against infection without any active agents."

More information about SBIR grants from the National Institutes of Health can be found at http://grants.nih.gov/grants/funding/sbir.htm.

About Healionics Corporation
Healionics develops and manufactures STAR® Biomaterials for implanted medical devices. The precisely controlled pore structure of the innovative STAR technology induces a favorable integrated healing response, overcoming fibrotic reactions and infection issues to enhance medical device performance and longevity.  The company has two medical device subsidiaries: iSTAR Medical and qSTAR Medical.

Websites:
     www.healionics.com 
     www.istarmed.com 
     www.qstarmed.com


'/>"/>
SOURCE Healionics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Eutropics Pharmaceuticals awarded NCI contract to develop companion diagnostic for guiding AML treatments
2. Managed Health Care Associates, Inc. (MHA) Awarded Commonwealth of Massachusetts GPO Contract
3. Sequent Medical, Inc. Awarded U.S. Patent for MicroBraid Technology
4. Avaxia Biologics is Awarded U.S. Patent for Antibody Therapy for Modulating Function of Intestinal Receptors and Methods of Treating Diabetes and Obesity
5. ChanTest Awarded $1 Million Grant for Predictive Assays using Stem Cell-Derived Human Cardiomyocytes
6. Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax
7. Antigen Discovery Inc. Awarded Phase I SBIR Grant to Develop a Fully Integrated Microfluidic Point of Care Diagnostic Device
8. Antigen Discovery, Inc. Awarded Phase II SBIR Grant to Identify Biomarkers Associated with Protection against Malaria
9. Luminex Corporation Awarded $11 Million Contract by Defense Threat Reduction Agency (DTRA)
10. Biodel Awarded NIH Grant to Develop Concentrated Ultra-Rapid-Acting Insulin Formulations for Use in Artificial Pancreas
11. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... FRANCISCO , February 28, 2017 The global  pulse ... a new report by Grand View Research, Inc. The pulse oximeters market is ... to the growing prevalence of target diseases such as chronic obstructive pulmonary disease ... Continue Reading ... Grand View Research ...
(Date:2/28/2017)... , Feb 28, 2017 Nordic Nanovector ASA (OSE: ... 2016. A presentation of the results by the company,s senior management ... Oslo - details below. ... 2016 was a very successful year for ... development of Betalutin®, progressed with our preclinical candidates and build the ...
(Date:2/27/2017)... Ga., Feb. 27, 2017 Halyard Health, Inc. (NYSE: ... 2016 results and provided its 2017 outlook and related key ... sales were $410 million, a 2 percent increase compared to ... fourth quarter 2016 was $10 million compared to net income ... quarter adjusted net income was $24 million compared to adjusted ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... February 28, 2017 , ... BrightStar Care Marietta announced that it has received ... Pulse. This award is granted only to top-ranking home care providers, based on client ... ranked among home care providers from across the country who have proven their ability ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... ... mass and overall body strength, which often leads to a host of health ... Journal of the American Geriatrics Society discovered that good overall muscle strength ...
(Date:2/27/2017)... (PRWEB) , ... February 27, 2017 , ... Much attention ... concern for women who become dependent on opioid painkillers has fallen short. From 1999 ... compared to a 237% increase in fatal overdoses in male populations.(1) , The proportion ...
(Date:2/27/2017)... ... February 27, 2017 , ... This webinar , sponsored ... a tool to characterize particle size distributions in the field of geoscience and ... novel scientific findings. It describes methods of optimized and standardized sample collection, preparation ...
(Date:2/27/2017)... Vancouver, BC (PRWEB) , ... February 27, 2017 ... ... top drug rehabilitation and alcohol treatment programs in British Columbia, Canada, at ... (RMT) to its team. The new hire, Mackenzie Alsager, showcases the Centre's commitment ...
Breaking Medicine News(10 mins):